Trial Profile
An open label, single-dose, randomized crossover study assessing absolute bioavailability of the active triazole, isavuconazole in healthy male volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jul 2016
Price :
$35
*
At a glance
- Drugs Isavuconazole (Primary) ; Isavuconazole (Primary)
- Indications Mycoses
- Focus Pharmacokinetics
- 11 Jul 2016 New trial record
- 27 Jun 2016 Results from EudraCT 2007-004949-15, EudraCT 2007- 004940-63 and NCT02128893 trials published in the International Journal of Clinical Pharmacology and Therapeutics